Phase i clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease

Molecular Biology Reports

Volumn 36, Issue 6, 2009, Pages 1323-1329

  Yang, Zhi Jian ^a   Zhang, You Rong ^b   Chen, Bo ^a   Zhang, Shu Lan ^a   Jia, En Zhi ^a   Wang, Lian Sheng ^a   Zhu, Tie Bing ^a   Li, Chun Jian ^a   Wang, Hui ^a   Huang, Jun ^a   Cao, Ke Jiang ^a   Ma, Wen Zhu ^a   Wu, Bin ^b   Wang, Li Sheng ^b   Wu, Chu Tse ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Angiogenesis; Coronary disease; Gene therapy; Genetics

Indexed keywords

ADENOVIRUS VECTOR; SCATTER FACTOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTERY CATHETER; ARTICLE; BALLOON; BYPASS SURGERY; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOLOGY; DRUG SAFETY; DRUG TOLERANCE; ELECTROCARDIOGRAM; FEMALE; FEVER; FOLLOW UP; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; MALE; PERICARDIAL EFFUSION; PHASE 1 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; STROKE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE;

ADENOVIRIDAE; AGED; AGED, 80 AND OVER; CATHETERIZATION; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE THERAPY; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; SAFETY; TREATMENT OUTCOME;

ADENOVIRIDAE;

EID: 67651099104     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-008-9315-3     Document Type: Article

References (24)

1. TK Rosengart SR Patel RG Crystal 1999 Therapeutic angiogenesis: protein and gene therapy delivery strategies J Cardiovasc Res 6 29 40
2. M Simons JA Ware 1996 Food for starving hearts Nat Med 2 519 520 10.1038/nm0596-519 (Pubitemid 26150675)
3. S Banai D Shweiki A Pinson M Chandra G Lazarovici E Keshet 1994 Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis Cardiovasc Res 28 1176 1179 10.1093/cvr/28.8.1176
4. J Li LF Brown MG Hibberd JD Grossman JP Morgan M Simons 1996 VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis Am J Physiol 270 H1803 H1811
5. F Bussolino MF Di Renzo M Ziche E Bocchietto M Olivero L Naldini 1992 Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth J Cell Biol 119 629 641 10.1083/jcb.119.3.629
6. E Jennische S Ekberg GL Matejka 1993 Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle Am J Physiol 265 C122 C128
7. K Ono A Matsumori T Shioi U Furukawa S Sasayama 1997 Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model Circulation 95 2552 2558
8. K Matsumoto T Nakamura 1996 Emerging multipotent aspects of hepatocyte growth factor J Biochem 119 591 600
9. H Fliss D Gattinger 1996 Apoptosis in ischemic and reperfused rat myocardium Circ Res 79 949 956
10. V Jayasankar YJ Woo TJ Pirolli LT Bish MF Berry J Burdick 2005 Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure J Card Surg 20 1 93 101 10.1111/j.0886-0440.2005.200373.x (Pubitemid 40175309)
11. J Azuma Y Taniyama Y Takeya K Iekushi M Aoki N Dosaka 2006 Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy Gene Ther 13 16 1206 1213 10.1038/sj.gt.3302740 (Pubitemid 44184714)
12. Y Li G Takemura K Kosai K Yuge S Nagano M Esaki 2003 Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice Circulation 107 2499 2506 10.1161/01.CIR.0000065579.19126.B8 (Pubitemid 36605235)
13. I Ahmet Y Sawa T Yamaguchi H Matsuda 2003 Gene transfer of hepatocyte growth factor improves angiogenesis and function of chronic ischemic myocardium in canine heart Ann Thorac Surg 75 4 1283 1287 10.1016/S0003-4975(02)04677-5 (Pubitemid 36399419)
14. M Aoki R Morishita Y Taniyama I Kida A Moriguchi K Matsumoto 2000 Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ETS Gene Ther 7 417 427 10.1038/sj.gt.3301104
15. Y Taniyama R Morishita M Aoki H Nakagami K Yamamoto K Yamazaki 2001 Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease Gene Ther 8 181 189 10.1038/sj.gt.3301379 (Pubitemid 32186129)
16. W Wang ZJ Yang DC Ma LS Wang SL Xu YR Zhang 2006 Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer Acta Pharmacol Sin 27 5 555 560 10.1111/j.1745-7254. 2006.00306.x
17. HF Duan CT Wu DL Wu Y Lu HJ Liu XQ Ha 2003 Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor Mol Ther 8 3 467 474 10.1016/S1525-0016(03)00186-2 (Pubitemid 37161468)
18. L Campeau 1976 Grading of angina pectoris Circulation 54 522 523
19. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG (1999) Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468-474
20. D Mukherjee DL Bhatt MT Roe V Patel SG Ellis 1999 Direct myocardial revascularization and angiogenesis-how many patients might be eligible? Am J Cardiol 84 5 598 600 10.1016/S0002-9149(99)00387-2 (Pubitemid 29408596)
21. ZJ Yang DC Ma W Wang SL Xu YQ Zhang B Chen 2006 Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction Gene Ther 13 22 1564 1568 10.1038/sj.gt.3302820 (Pubitemid 44696121)
22. R Morishita M Aoki N Hashiya H Makino K Yamasaki J Azuma 2004 Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease Hypertension 44 2 203 209 10.1161/01.HYP.0000136394. 08900.ed (Pubitemid 39014240)
23. BG Harvey J Maroni KA O'Donoghue 2002 Safety of local delivery of low-and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions Hum Gene Ther 13 1 15 63 10.1089/10430340152712638 (Pubitemid 34075172)
24. S Worgall G Wolff E Falck-Pedersen RG Crystal 1997 Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration Hum Gene Ther 8 37 44 10.1089/hum.1997.8.1-37